This study aimed to evaluate the predictive value of a novel biomarker (N-myc and STAT interactor (NMI)) in assessing disease severity and clinical outcome in sepsis.<h4>Methods</h4>A total of 399 adult patients diagnosed with sepsis were recruited. Here, MYCN is linked to Sepsis.